Literature DB >> 8543517

Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.

D F Connor1, S Benjamin, K R Ozbayrak.   

Abstract

Risk factors for neuroleptic withdrawal dyskinesia in children have not been well studied. The authors present a case of a child who had been treated with a combination of neuroleptics and stimulants for nonpsychotic aggressive behavior. A severe withdrawal dyskinesia precipitated by neuroleptic tapering was ameliorated by discontinuation of the psycho-stimulant. Although stimulants have been reported to increase certain involuntary movement disorders, this is the first known report of psychostimulant exacerbation of withdrawal dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543517

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  2 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis.

Authors:  Luke Blagdon Snell; Dinkar Bakshi
Journal:  BMJ Case Rep       Date:  2015-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.